Robert H. Brookline Rubin
#109,063
Most Influential Person Now
Robert H. Brookline Rubin's AcademicInfluence.com Rankings
Robert H. Brookline Rubinphilosophy Degrees
Philosophy
#4524
World Rank
#7074
Historical Rank
Logic
#1957
World Rank
#2837
Historical Rank

Download Badge
Philosophy
Robert H. Brookline Rubin's Degrees
- Doctorate Medicine Harvard University
Why Is Robert H. Brookline Rubin Influential?
(Suggest an Edit or Addition)Robert H. Brookline Rubin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (2002) (3019)
- Infection in organ-transplant recipients. (1998) (953)
- Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. (2007) (544)
- Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. (1981) (485)
- Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (435)
- Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. (1981) (431)
- Impact of cytomegalovirus infection on organ transplant recipients. (1990) (426)
- International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. (1997) (422)
- Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. (2003) (406)
- Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. (1990) (355)
- Infectious disease complications of renal transplantation. (1993) (350)
- Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. (1981) (347)
- Infection in the renal transplant recipient. (1981) (337)
- NEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS (1978) (305)
- The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. (1997) (299)
- Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. (1979) (269)
- Infections and anti–tumor necrosis factor α therapy (2003) (269)
- Clinical, microbiologic and therapeutic aspects of purulent pericarditis. (1975) (268)
- Clinical Approach to Infection in the Compromised Host (2002) (250)
- Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients (1995) (247)
- Infection in the Organ Transplant Recipient (1994) (240)
- Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. (1995) (229)
- SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2 (1992) (225)
- Infections and anti-tumor necrosis factor alpha therapy. (2003) (222)
- The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. (1989) (221)
- 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. (1989) (205)
- Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. (1978) (201)
- Cytomegalovirus prophylaxis in solid organ transplant recipients. (1996) (188)
- Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. (1981) (187)
- Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. (1974) (186)
- BK virus in solid organ transplant recipients: an emerging syndrome. (2001) (179)
- INFECTIOUS DISEASE SYNDROMES ATTRIBUTABLE TO CYTOMEGALOVIRUS AND THEIR SIGNIFICANCE AMONG RENAL TRANSPLANT RECIPIENTS (1977) (179)
- Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. (1983) (173)
- Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli (1989) (171)
- MULTICENTER SEROEPIDEMIOLOGIC STUDY OF THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON RENAL TRANSPLANTATION (1985) (164)
- Preemptive therapy in immunocompromised hosts. (1991) (162)
- Central Nervous System Infection in the Chronically Immunosuppressed (1982) (159)
- Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts (1981) (157)
- Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. (2001) (156)
- Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. (1986) (149)
- A serological investigation of BK virus and JC virus infections in recipients of renal allografts. (1988) (147)
- Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. (1983) (141)
- Glomerulopathy associated with cytomegalovirus viremia in renal allografts. (1981) (140)
- Clinical aspects of fungal infection in organ transplant recipients. (1994) (131)
- Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. (1995) (130)
- Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis (2000) (125)
- The Renal Transplant Patient with Fever and Pulmonary Infiltrates: Etiology, Clinical Manifestations, and Management (1980) (120)
- Epstein-Barr virus infection in renal transplant recipients. Effects of antithymocyte globulin and interferon. (1980) (120)
- Dermatologic Manifestations of Infections in Immunocompromised Patients (1985) (117)
- Cytomegalovirus infection in dialysis patients and personnel. (1978) (114)
- Varicella in pediatric renal transplant recipients. (1992) (113)
- A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. (1982) (108)
- EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION (1984) (107)
- Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. (1988) (105)
- Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients (2004) (105)
- The release of four mediators of immediate hypersensitivity from human leukemic basophils. (1975) (104)
- Impact of hepatitis on renal transplantation. (1981) (101)
- Single-Dose Amoxicillin Therapy for Urinary Tract Infection: Multicenter Trial Using Antibody-Coated Bacteria Localization Technique (1980) (101)
- Detection of acute inflammation with 111In-labeled nonspecific polyclonal IgG. (1988) (100)
- Salmonellosis: Microbiologic, pathologic, and clinical features (1977) (97)
- Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. (2005) (96)
- Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. (1993) (96)
- Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. (1997) (96)
- Radiolabeled, nonspecific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and technetium-99m-labeled albumin. (1989) (91)
- Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. (1991) (91)
- The spectrum of Salmonella infection. (1988) (89)
- Autoradiographic method for quantitation of radiolabeled proteins in tissues using indium-111. (1989) (87)
- Surgical wound infection: epidemiology, pathogenesis, diagnosis and management (2006) (87)
- Antimicrobial strategies in the care of organ transplant recipients (1993) (87)
- The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the ‘silo hypothesis’ (2007) (86)
- Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. (1990) (85)
- Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography (1993) (83)
- Pharmacokinetic Imaging (2002) (82)
- Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS (1993) (80)
- USE OF ANTITHYMOCYTE GLOBULIN FOR REVERSAL OF ACUTE ALLOGRAFT REJECTION (1979) (80)
- Clinical Approach to Infection in the Compromised Host (2002) (78)
- The acquired immunodeficiency syndrome and transplantation. (1987) (78)
- Infection of the central nervous system in organ transplant recipients. (1988) (77)
- A murine model of myocardial microvascular thrombosis. (1999) (76)
- Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients. (1999) (76)
- IGA NEPHROPATHY IN HLA‐IDENTICAL SIBLINGS (1978) (76)
- Hepatitis C virus and organ transplantation. (1996) (75)
- From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. (1979) (75)
- Infection in the Renal and Liver Transplant Patient (1988) (73)
- Uremia and host defenses. (1990) (72)
- Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. (1984) (71)
- Prevention and treatment of cytomegalovirus disease in heart transplant patients. (2000) (71)
- Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole1 (2003) (71)
- Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy (2003) (69)
- Mononuclear cells in acute allograft glomerulopathy. (1987) (69)
- In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. (1993) (65)
- The effect of infection on T lymphocyte subpopulations: a preliminary report. (1981) (64)
- Short-Course Ciproflox Treatment of Acute Uncomplicated Urinary Tract Infection in Women: The Minimum Effective Dose (1995) (64)
- Cytokines as potential vaccine adjuvants (1994) (64)
- Approach to immunization in the immunosuppressed host. (1990) (63)
- Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. (1993) (63)
- Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. (1996) (63)
- Adverse reactions to duck embryo rabies vaccine. Range and incidence. (1973) (61)
- The hepatotoxicity of antifungal medications in bone marrow transplant recipients. (2005) (61)
- Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. (1981) (61)
- Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. (1978) (61)
- Amoxicillin and Potassium Clavulanate: An Antibiotic Combination Mechanism of Action, Pharmacokinetics, Antimicrobial Spectrum, Clinical Efficacy and Adverse Effects (1984) (60)
- Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. (1989) (57)
- Evolving trends in liver transplantation: an outcome and charge analysis. (1998) (57)
- IMMUNOGENICITY OF HEPATITIS B VACCINE IN RENAL TRANSPLANT RECIPIENTS (1985) (57)
- The prevention of infection post‐transplant: the role of prophylaxis, preemptive and empiric therapy (2006) (56)
- The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV) (1988) (56)
- Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. (1989) (56)
- Viral infection in the renal transplant recipient (1992) (55)
- The role of positron emission tomography in pharmacokinetic analysis. (1997) (55)
- Invasive aspergillus infection: possible non-ward common source within the hospital environment. (1989) (54)
- Cytomegalovirus in solid organ transplantation (2001) (54)
- The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies (1999) (53)
- Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. (1982) (53)
- Infection imaging with technetium-99m-labeled chemotactic peptide analogs. (1994) (52)
- A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. (1970) (51)
- Pharmacokinetics of [18F]Trovafloxacin in Healthy Human Subjects Studied with Positron Emission Tomography (1998) (50)
- Noninvasive renal diagnostic studies. (1988) (50)
- The use of radiolabeled nonspecific immunoglobulin in the detection of focal inflammation. (1994) (49)
- Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant‐induced gastrointestinal toxicities (2001) (49)
- Infection in the Renal Transplant Patient (1982) (48)
- Opportunistic fungal and bacterial infection in the renal transplant recipient. (1992) (47)
- The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management. (2002) (45)
- Mapping of local renal blood flow with PET and H(2)(15)O. (2002) (45)
- The compromised host as sentinel chicken. (1987) (44)
- Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. (1998) (43)
- An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury. (1996) (42)
- An approach to evaluating antibacterial agents in the treatment of urinary tract infection. (1992) (42)
- The problem of human immunodeficiency virus (HIV) infection and transplantation (1988) (42)
- Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. (1992) (41)
- Interferon and BK Papovavirus--clinical and laboratory studies. (1980) (41)
- The impact of infection on the outcome of transplantation. (1991) (41)
- Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. (1992) (40)
- Prevention dof recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir (2000) (39)
- Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli (1989) (39)
- Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. (1976) (39)
- Infection in the organ transplant recipient. An overview. (1995) (38)
- Central nervous system infection in the compromised host. (1985) (38)
- Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. (1979) (38)
- Postexposure rabies prophylaxis with human rabies immune globulin. (1974) (38)
- Utility of the indium 111-labeled human immunoglobulin G scan for the detection of focal vascular graft infection. (1989) (37)
- Dietary marine lipid does not alter susceptibility of (NZBxNZW)F1 mice to pathogenic microorganisms. (1989) (36)
- Bacteremic hemophilus influenzae type B cellulitis in the adult. (1977) (36)
- Dermatologic manifestations of infection in the compromised host. (1983) (36)
- Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. (2001) (36)
- New developments in cytomegalovirus prevention and management. (1993) (35)
- Isolation of adenovirus type 34 from a renal transplant recipient with interstitial pneumonia. (1977) (35)
- Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. (1986) (34)
- Noninvasive, real-time monitoring of renal function during critical care. (1994) (34)
- Infection: the new problems. (1989) (34)
- Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. (1983) (33)
- Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice (1989) (33)
- USEFULNESS OF THE ANTIBODY‐COATED BACTERIA ASSAY IN THE MANAGEMENT OF URINARY TRACT INFECTION IN THE RENAL TRANSPLANT PATIENT (1979) (33)
- Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. (2006) (33)
- Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. (1983) (33)
- Single-Dose Amoxicillin Therapy for Urinary Tract Infection-Reply (1981) (33)
- New approaches to the treatment of urinary tract infection. (1987) (33)
- Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection. (1992) (32)
- Accumulation of immunoglobulin G at focal sites of inflammation (2004) (32)
- Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir. (1999) (32)
- Primary cytomegalovirus infection following cardiac transplantation in a murine model. (1984) (31)
- Cure of hemophilia A by orthotopic liver transplantation. (1988) (30)
- Importance of CMV in the transplant population. (1999) (30)
- Renal transplantation and related infections. (1993) (30)
- Adenosine deaminase binding protein, a new diagnostic marker for kidney disease. (1985) (30)
- Viral infection in the renal transplant patient. (1983) (29)
- The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. (1986) (29)
- Disseminated Mycobacterium avium‐intracellulare in a kidney transplant recipient (2001) (29)
- Safety and efficacy of granulocyte colony‐stimulating factor in kidney and liver transplant recipients (2000) (27)
- Lack of effect of hepatitis B vaccine on T-cell phenotypes. (1984) (26)
- Single-dose amoxicillin therapy of acute uncomplicated urinary tract infections in women (1984) (26)
- Effects of long-term lithium administration on renal structure and function in rats. A distinctive tubular lesion. (1984) (26)
- Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography (1996) (26)
- 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice (1987) (26)
- Immunoglobulin response to rabies vaccine in man. (1971) (26)
- Antithymocyte globulin as the primary treatment for renal allograft rejection. (1983) (25)
- Editorial Response: Cytomegalovirus Disease and Allograft Loss After Organ Transplantation (1998) (25)
- Solid organ transplantation in HIV-infected individuals: obstacles and opportunities. (2001) (25)
- Etiology and Management of the Compromised Patient with Fever and Pulmonary Infiltrates (1988) (25)
- 18F-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219). (1996) (25)
- Safety and efficacy of granulocyte colony-stimulating factor in kidney and liver transplant recipients. (1999) (24)
- Immunization strategies for the immunocompromised host: the need for immunoadjuvants. (1989) (24)
- Overview: pathogenesis of fungal infections in the organ transplant recipient. (2002) (24)
- Fungal and bacterial infections in the immunocompromised host (2006) (23)
- Escherichia coli-specific T lymphocytes in experimental pyelonephritis. (1988) (23)
- Systemic salmonellosis in patients with disseminated histoplasmosis. Case for 'macrophage blockade' caused by Histoplasma capsulatum. (1987) (22)
- Opportunistic infections in renal allograft recipients. (1988) (22)
- Recent advances in the diagnosis and management of infection in the organ transplant recipient. (2000) (22)
- Combined kidney and pancreas transplantation in diabetics. (1988) (21)
- Empiric antibacterial therapy in granulocytopenia induced by cancer chemotherapy. (1988) (21)
- Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits. (1993) (21)
- Understanding and diagnosing infectious complications in the immunocompromised host. Current issues and trends. (1993) (21)
- A consideration of potential donors with active infection – is this a way to expand the donor pool? (1998) (20)
- Cell-mediated immunity in experimental cytomegalovirus infections: a perspective. (1990) (20)
- Rabies in citizens of the United States, 1963-1968: epidemiology, treatment, and complications of treatment. (1969) (20)
- Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein. (1987) (20)
- Imaging of Pneumocystis carinii pneumonia with 111In‐labelled non‐specific polyclonal IgG: an experimental study in rats (1991) (20)
- BK papovavirus infections in renal transplant recipients: contribution of donor kidneys. (1982) (19)
- Activation of latent murine cytomegalovirus in cardiac explant and cell cultures. (1985) (19)
- Case record of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2003. A 43-year-old man with fever, rapid loss of vision in the left eye, and cardiac findings. (2003) (19)
- Viral infections in organ transplantation. (1998) (18)
- Liver disease in the organ transplant recipient: Etiology, clinical impact, and clinical management (1991) (18)
- EVOLVING TRENDS IN LIVER TRANSPLANTATION (1999) (18)
- Immunologic monitoring with monoclonal antibodies to human T-cell subsets. (1981) (18)
- Opportunistic infections in the cardiac transplant patient. (1996) (18)
- The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization. (1986) (18)
- The bidirectional relationship between cytomegalovirus and allograft injury. (2001) (17)
- T-lymphocyte subset phenotypes: a multisite evaluation of normal subjects and patients with AIDS. (1985) (17)
- Smallpox vaccination and the patient with an organ transplant. (2003) (17)
- Cytomegalovirus disease and allograft loss after organ transplantation. (1998) (17)
- Localization and antibiotic management of urinary tract infection. (1979) (16)
- Cytomegalovirus excretion 2-14 years after renal transplantation. (1979) (16)
- Prevention of cytomegalovirus infection in organ transplant recipients (2000) (16)
- Mycobacterial and Nocardial Diseases in the Compromised Host (2002) (16)
- The infectious disease problems of the diabetic renal transplant recipient. (1995) (16)
- Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management. (1997) (15)
- Synthesis of a 11C-labeled NK1 receptor ligand for PET studies. (1995) (15)
- Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. (1996) (15)
- Urinary tract infection: significance and management. (1986) (15)
- Management of Tuberculosis in the Transplant Recipient (2005) (15)
- Detection of acute bacterial infection within soft tissue injuries using a 99mTc-labeled chemotactic peptide. (1995) (14)
- POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER AND OKT3. REPLY (1991) (14)
- Clinical Approach to the Compromised Host with Fever and Pulmonary Infiltrates (2002) (14)
- Radionuclide imaging of infection in the immunocompromised host. (1996) (14)
- Fluconazole in the Treatment of Invasive Candidal and Cryptococcal Infections in Organ Transplant Recipients (1990) (14)
- Synthesis and biodistribution of 18F-labeled fleroxacin. (1993) (14)
- Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies. (2009) (14)
- Preparation and pharmacokinetics of 11C labeled stavudine (d4T). (2004) (13)
- Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy (2006) (13)
- The interaction of immunosuppression with infection in the organ transplant recipient. (1994) (13)
- Risks versus benefits of contrast medium exposure in renal allograft recipients. (1983) (13)
- Clinical approach to viral and fungal infections in the renal transplant patient. (1992) (13)
- Effect of isoelectric point on biodistribution and inflammation imaging with indium-111-labelled IgG (2004) (13)
- In Vivo Imaging in Drug Discovery and Design (1994) (13)
- Human rabies immune globulin. Clinical trials and effects on serum anti- -globulins. (1973) (12)
- Transplant infectious disease: a moving target (2008) (12)
- Ciprofloxacin in management of urinary tract infection. (1988) (12)
- Changes in the phenotype of T-cell subset determinants following murine cytomegalovirus infection. (1986) (12)
- The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. (1987) (12)
- Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency (1985) (11)
- Real-time monitoring of renal function during ischemic injury in the rhesus monkey. (1995) (11)
- Effect of interferon alpha on natural killer cell cytotoxicity in kidney transplant recipients. (1984) (11)
- T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis. (1993) (10)
- FUNGAL INFECTION IN THE ORGAN TRANSPLANT RECIPIENT (1998) (10)
- Postmenopausal tubo-ovarian abscess due to Pseudomonas aeruginosa in a renal transplant patient: a case report and review of the literature. (2001) (10)
- Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. (1997) (10)
- Sucdessful hemodialysis of patients at high risk of hemorrhage using the exVal dialyzer (1986) (10)
- Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. (1981) (9)
- In vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody. (1996) (9)
- Clinical Management of Urinary Tract Infection (1982) (9)
- Post transfusion viral infections. (1988) (9)
- Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits (2004) (8)
- Comparison of 99Tcm-labelled monoclonal anti‐granulocyte antibody and 111 In‐labelled IgG for the detection of focal sites of infection in rats (1991) (8)
- Studies of immediate hypersensitivity in a patient with Acanthocheilonema perstans filarial infection. (1975) (8)
- Prevention of infection in the liver transplant recipient. (1996) (8)
- Pharmacokinetics of 18F-labeled trovafloxacin in normal and Escherichia coli-infected rats and rabbits studied with positron emission tomography. (1997) (8)
- Thein vivo andin vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection (1989) (8)
- The therapeutic prescription for the transplant patient (2002) (7)
- Protective effects of E5, an antiendotoxin monoclonal antibody, in the ovine pulmonary circulation. (1993) (7)
- Overview of pneumonia in the compromised host. (1986) (7)
- Imaging of focal sites of inflammation in rhesus monkeys with 99mTc-labeled human polyclonal IgG. (1994) (6)
- 1506 SINGLE DOSE AMOXICILLIN (S) TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS (UTI) AS EFFECTIVE AS CONVENTIONAL THERAPY (C) (1981) (6)
- Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327. (1998) (6)
- Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin. (1993) (6)
- Humoral and cellular immune response in ocular histoplasmosis. (1985) (6)
- Temporal aspects of transplant infectious disease (2003) (6)
- Poorer outcomes for recipients of heart allografts from HCV-positive donors: opening the silos. (2006) (6)
- Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation. (1982) (6)
- The prevention and treatment of infectious disease in the transplant patient: where are we now and where do we need to go? (2004) (6)
- Changes in immunoregulatory lymphocyte populations in patients with histoplasmosis (1984) (6)
- Regional pharmacokinetics of orally administered PET tracers. (2000) (6)
- Principles of antimicrobial therapy in the transplant recipient (2004) (6)
- Competitive idiotype--anti-idiotype immunoassay for adenosine deaminase binding protein in urine. (1985) (6)
- Infection and T lymphocyte subpopulations: changes associated with bacteremia and the acquired immunodeficiency syndrome. (1983) (6)
- Prevention of cytomegalovirus infection in the pediatric renal transplant recipient (2004) (6)
- The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients. (2004) (6)
- Principles of antimicrobial therapy in the transplant patient (2004) (5)
- Positron emission tomography in drug development. (1997) (5)
- Minimizing the toxicity of antilymphocyte antibody therapy. (1996) (5)
- Transplant infectious disease in the twenty-first century (2001) (4)
- Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography. (1994) (4)
- Cytomegalovirus in the transplant population: current issues and future directions. Discussion and consensus points. (1999) (4)
- Infections of the Urinary Tract (1998) (4)
- The persistent challenges of bacterial infections in the transplant recipient (2006) (4)
- The effects of donor pretreatment on the transmission of murine cytomegalovirus with cardiac transplants and explants. (1986) (4)
- Polyclonal, nonspecific 111In-IgG scintigraphy in the evaluation of complicated osteomyelitis and septic arthritis. (1999) (4)
- Single-Dose Amoxicillin Therapy of Uncomplicated Pediatric Urinary Tract Infections (1983) (4)
- Psychiatric disease and cytomegalovirus viremia in renal transplant recipients. (1995) (4)
- Infection in the organ transplant patient; the Hegelian dialectic of transplantation. (1994) (3)
- The value of randomized clinical trials for daily clinical practice (2007) (3)
- Trends, challenges and promotion of clinical and cardiovascular research in Latin America and the Caribbean (2006) (3)
- 503 5HT2 and D2 receptor occupancy of ziprasidone in healthy volunteers (1997) (3)
- Transplant infectious disease: a work in progress (2005) (3)
- Reply to Verweij et al (2007) (3)
- Case 1-2006: A 64-Year-Old Male Lung-Transplant Recipient with Fever, Cough, Hemoptysis, and Abdominal Pain (2006) (3)
- Opportunities and Challenges for Clinical and Cardiovascular Research in Latin America (2006) (3)
- The problem of human immunodeficiency virus infection in dialysis and transplantation: the need for an international registry (1988) (3)
- Urinary Tract Infection and the Immunocompromised Host: UTI in Renal Transplant Patients (1997) (3)
- St. Louis encephalitis in Saline County, Illinois, 1968. (1970) (3)
- Non-tumor applications of radioimmune imaging. (1991) (3)
- Fungal Infection in the Organ Transplant Recipient: Challenges and Opportunities (1996) (3)
- Influenza and the transplant recipient (2002) (3)
- P-17-2 Sustained 5HT2A receptor occupancy of ziprasidone using pet ligand 18F setoperone in healthy volunteers (1996) (3)
- Fever, Neutropenia, and the Second Law of Thermodynamics (2002) (3)
- Expanding the envelope: can we increase the organ donor pool through the appropriate application of infectious disease principles? (2002) (3)
- Chapter 37 – Therapy of Urinary Tract Infection (2008) (2)
- Pushing the envelope: transplantation and emerging infections (2000) (2)
- The role of new diagnostic tests in transplant infectious disease (2002) (2)
- The Role of Interferons in Viral Infections in Immune Compromised Patients (1984) (2)
- Control of hepatitis in the transplant patient: a journey begun – but not there yet (2000) (2)
- Transplant infectious disease as a subspecialty: does outlining how we train define who we are? (2009) (2)
- Infection, antimicrobial resistance, and newly emerging pathogens: the growing role of fungi. (2001) (2)
- Transplantation and the Second Law of Thermodynamics. (1999) (2)
- Antimicrobial prophylaxis in patients undergoing solid organ transplantation. (1995) (2)
- Cytomegalovirus and transplantation: yesterday, today, and tomorrow. (1999) (2)
- Human Rabies Immune Globulin: Clinical Trials and Effects on Serum Anti-γ-Globulins (1973) (2)
- MINIREVIEW Antimicrobial Strategies intheCareofOrgan Transplant Recipients (1993) (2)
- PET as a biomarker of the antitumor effects of the CDK2 inhibitor BMS-387032. (2004) (2)
- The use of cytomegalovirus cmv immune globulin cmvig for prevention of cmv disease in patients undergoing liver transplantation (1991) (1)
- Granulomatous infections in the transplant patient (2003) (1)
- Renal transplantation in the highly sensitized recipient. (1987) (1)
- Chapter 75 – Infection in solid organ transplantation (2010) (1)
- Immunological monitoring of diabetic and nondiabetic recipients of renal allografts. (1983) (1)
- Pulmonary infection in solid organ transplant recipients. (1990) (1)
- The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection (2017) (1)
- Infections in transplant patients and the role of the microbiology laboratory (1991) (1)
- Imaging Techniques in Pharmacology (1991) (1)
- Editorial (1999) (1)
- Community-Acquired Pneumonia in the Immunocompromised Host (2002) (1)
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts (1982) (1)
- A consideration of potential donors with active infection ‐ is this a way to expand the donor pool? (1998) (1)
- INTERFERON IN RENAL TRANSPLANT RECIPIENTS (1982) (1)
- Use of T cell subset monitoring in the study of clinical infectious disease problems (1986) (1)
- Registry—Acquired Immunodeficiency Syndrome and Clinical Transplantation (1987) (1)
- Control of Herpesvirus Infection in Organ Transplant Recipients (1993) (1)
- Editorial (1999) (0)
- Opportunistic Infect ions in Renal Allograft Recipients (2013) (0)
- Preemptive Ganciclovir Therapy in Renal Transplantation (1996) (0)
- The Mucocutaneous Problems Associated with Human Immunodeficiency Virus Infection (1994) (0)
- Epstein-Barr Virus Infection in Renal Transplant Recipients (2020) (0)
- Use of a detectably labeled immunoglobulin or a fragment thereof for producing an agent for the detection of an inflammation site in vivo. (1987) (0)
- Antiviral therapy―An anti-malignancy strategy for transplant recipients? (1992) (0)
- Editorial (2000) (0)
- Case 31-1985: A 43-Year-Old Man with Nine Years of Fever of Unknown Origin (1985) (0)
- Letters to the Editor Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole (2003) (0)
- The use of antimicrobial drugs in transplant patients. (2001) (0)
- Editorial (2001) (0)
- Synthesis of 5-[11C-methyl]-2′-3′-didehydro-3′-deoxythymidine (11C-d4T) (2001) (0)
- Case records of the Massachusetts General Hospital. Case 1-2006. A 64-year-old male lung-transplant recipient with fever, cough, hemoptysis, and abdominal pain. (2006) (0)
- 190: Potential for Racial Disparities in the Proposed Medicare Dialysis Prospective Payment System (2010) (0)
- An introduction to organ transplantation. I. (1989) (0)
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT 3 MONOCLONAL ANTIBODY 1 A (2017) (0)
- HST.151 Principles of Pharmacology, Spring 2003 (2003) (0)
- Labeled chemotactic peptides for visualization of inflammation and infection sites. (1990) (0)
- Infectious Diseases of Transplantation Web Course and e-Conference Room: Building an International Community of Clinicians (2005) (0)
- Opportunities and challenges in infectious disease research for the twenty-first century. (1998) (0)
- Noninvasive diagnosis of Pneumocystis carinii in the rat using radiolabeled, nonspecific, human polyclonal immunoglobulin. (1989) (0)
- P&T Committee review of fluconazole: an effective alternative to antifungal therapy. (1990) (0)
- Halo Sign and Improved Outcome. Authors' reply (2007) (0)
- A murine model of myocardial microvascular thrombosis this access benefits you. Your story matters (1999) (0)
- Cell-Mediated Immunity in Experimental Cytomegalovirus Infections: (1990) (0)
- PROPHYLACTIC E5 PROTECTS AGAINST THE HEMODYNAMIC CONSEQUENCES OF ENDOTOXIN (LPS) CHALLENGE IN RABBITS (1993) (0)
- Role of radionuclide studies in drug development and evaluation (1992) (0)
- Urinary tract infections in women. (1979) (0)
- Humoral and cellular immune response in ocular histoplasmosis. (1985) (0)
- THE INFLUENCE OF HUMAN ANTI-MOUSE ANTIBODY (HAMA) INDUCED BY OKT3 ON THE PROTECTIVE EFFECTS OF E5 IN A SHEEP MODEL OF ARDS (1993) (0)
- sensitivity in HIV-lipodystrophy Depot-specific regulation of glucose uptake and insulin (2016) (0)
- Infection in Patients Undergoing Thoracic Organ Transplantation: Epidemiology, Pathogenesis, and Clinical Management (1996) (0)
- Introduction to the Symposium (1990) (0)
- Editorial (1999) (0)
- Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient * (2005) (0)
- Measurement of tissue pharmacokinetics of antimicrobial agents by positron emission tomography (1999) (0)
- Editorial (2001) (0)
- Editorial (2001) (0)
- Editorial (2001) (0)
- The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodificiency virus (HIV) (1990) (0)
- The labeled chemotactic peptides of infection or inflammation of the entries describe the (1996) (0)
- Diagnosis of opportunistic infections in the transplant patient (2003) (0)
- Prevents DeathbutNot Immunity inMurineCytomegalovirus-Infected Normaland (1987) (0)
- Individualization in the management of fungal disease in the transplant recipient (2007) (0)
- Cytomegalovirus in the transplant population: current issues and future directions. An introduction to the symposium. (1999) (0)
- Editor's introduction to guest editorial (2004) (0)
- Radionuclide imaging of infection in soft tissue and bone. (1997) (0)
- Vol. 8, No. 1, 2006 (2006) (0)
- Effect of isotype on the biodistribution of radioiodinated immunoglobulins (1985) (0)
- Art and science in the clinical management of the patient with infection and/or cancer (2004) (0)
- persons with AIDS. correlations in transplant recipients and in Cytomegalovirus antigenemia: clinical (2013) (0)
- The Acquired lmmunodeficiency Syndrome ( AIDS ) and Infection with Human lmmunodeficiency Virus ( HIV ) (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert H. Brookline Rubin?
Robert H. Brookline Rubin is affiliated with the following schools: